Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total Neoadjuvant Therapy in Rectal Cancer
NCT06162650Phase 2Recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- Nov 2023
- Primary completion
- Nov 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mFOLFOX6 in rectal cancer, sponsored by National Cheng Kung University Hospital. Started Nov 2023; status: recruiting.
02
Drugs
mFOLFOX6
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06162650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06162650.